Your Health, We Care

Home >Drug List>Pemigatinib>Indications of Pemigatinib

Pemigatinib(LuciPem)

Release date: 2026-01-06 10:30:25     Recommended: 277

Used for the treatment of advanced, unresectable cholangiocarcinoma with FGFR2 gene fusion or rearrangement.